SCHEMBL5420494

SCHEMBL5420494

CCc1nc2c(C)cc(C)nc2n1Cc1cccc(C(O)c2ccc(CO[Si](C)(C)C(C)(C)C)cc2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5417453 0.96 — —
SCHEMBL5427798 0.85 — —
SCHEMBL5422429 0.83 AGTR1 (0.48) —
SCHEMBL5426654 0.82 AGTR1 (0.48) —
SCHEMBL5420492 0.82 — —
SCHEMBL5417443 0.81 — —
SCHEMBL5417450 0.79 — —
SCHEMBL5780702 0.78 AGTR1 (0.45) —
SCHEMBL5780678 0.76 — —
SCHEMBL5417503 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507484-B2 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-08-13 — — US disclosed
US-20070213361-A1 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases KYOWA KIRIN CO., LTD. (JP) 2007-09-13 — — US disclosed
EP-1724271-A1 PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUTROPHILIC INFLAMMATION DISEASE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-22 — — EP disclosed
Send feedback